SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference | ICU Stock News
I'm PortAI, I can summarize articles.
SeaStar Medical Holding Corporation (Nasdaq: ICU) announced that CEO Eric Schlorff will present at the Biotech Showcase 2026 Investor Conference on January 13, 2026, at 3:00 p.m. PST. The presentation will be available live on the company's website, with a replay accessible for 30 days post-event. Additionally, SeaStar's management will meet with investors during the J.P. Morgan Healthcare Conference from January 12-14, 2026. SeaStar focuses on treatments for critically ill patients, with its QUELIMMUNE therapy being the first FDA-approved product for life-threatening acute kidney injury in pediatric patients.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: StockTitan The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments